��������

Ayman AlAbdallah is a Partner at Mubadala Capital and serves as an Investor and Board member for multiple companies including Iambic Therapeutics, Georgiamune Inc., Precision Neuroscience, and UpStream. Ayman holds a Bachelor of Applied Science (B.A.Sc.) degree in Mechanical Engineering from the University of Toronto.